474 related articles for article (PubMed ID: 29241640)
1. Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study.
Alemao E; Guo Z; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME
Semin Arthritis Rheum; 2018 Apr; 47(5):630-638. PubMed ID: 29241640
[TBL] [Abstract][Full Text] [Related]
2. Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis.
Harrold LR; Shan Y; Connolly SE; Alemao E; Rebello S; Guo L; Kremer JM
Curr Med Res Opin; 2020 Feb; 36(2):337-342. PubMed ID: 31612736
[No Abstract] [Full Text] [Related]
3. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.
Huang S; He X; Doyle TJ; Zaccardelli A; Marshall AA; Friedlander HM; Blaustein RB; Smith EA; Cui J; Iannaccone CK; Mahmoud TG; Weinblatt ME; Dellaripa PF; Shadick NA; Sparks JA
Clin Rheumatol; 2019 Dec; 38(12):3401-3412. PubMed ID: 31410660
[TBL] [Abstract][Full Text] [Related]
4. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T
Arthritis Res Ther; 2017 Sep; 19(1):194. PubMed ID: 28865493
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
[TBL] [Abstract][Full Text] [Related]
7. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.
Tan YK; Li H; Allen JC; Thumboo J
Int J Rheum Dis; 2020 Oct; 23(10):1337-1343. PubMed ID: 33460311
[TBL] [Abstract][Full Text] [Related]
8. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
[TBL] [Abstract][Full Text] [Related]
9. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
Kamalaksha S; White DHN; Solanki KK
Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.
Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K
RMD Open; 2019; 5(1):e000742. PubMed ID: 30886732
[TBL] [Abstract][Full Text] [Related]
11. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A
Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148
[TBL] [Abstract][Full Text] [Related]
12. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
[TBL] [Abstract][Full Text] [Related]
13. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
Karlson EW; Chibnik LB; Cui J; Plenge RM; Glass RJ; Maher NE; Parker A; Roubenoff R; Izmailova E; Coblyn JS; Weinblatt ME; Shadick NA
Ann Rheum Dis; 2008 Mar; 67(3):358-63. PubMed ID: 17666451
[TBL] [Abstract][Full Text] [Related]
14. Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis.
Perry E; Eggleton P; De Soyza A; Hutchinson D; Kelly C
Int J Rheum Dis; 2017 Dec; 20(12):2003-2011. PubMed ID: 26200759
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
[TBL] [Abstract][Full Text] [Related]
16. Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis.
Gudowska M; Gindzienska-Sieskiewicz E; Gruszewska E; Cylwik B; Sierakowski S; Szmitkowski M; Chrostek L
Rev Bras Reumatol Engl Ed; 2017; 57(3):185-189. PubMed ID: 28535888
[TBL] [Abstract][Full Text] [Related]
17. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
[TBL] [Abstract][Full Text] [Related]
18. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
Inanc N; Dalkilic E; Kamali S; Kasapoglu-Günal E; Elbir Y; Direskeneli H; Inanc M
Clin Rheumatol; 2007 Jan; 26(1):17-23. PubMed ID: 16538391
[TBL] [Abstract][Full Text] [Related]
19. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.
Cheng TT; Yu SF; Su FM; Chen YC; Su BY; Chiu WC; Hsu CY; Chen JF; Ko CH; Lai HM
Arthritis Res Ther; 2018 Jan; 20(1):16. PubMed ID: 29382355
[TBL] [Abstract][Full Text] [Related]
20. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
